Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2001-3-22
pubmed:abstractText
Twenty-seven consecutive Italian patients with Fanconi's anaemia (FA) underwent stem cell transplantation (SCT) from an HLA-matched related donor in 10 Italian centres of the Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP), Gruppo Italiano di Trapianto di Midollo Osseo (GITMO). Twenty-two patients (81.5%) were conditioned with low-dose (median 20 mg/kg) cyclophosphamide (Cy) and thoraco-abdominal or total body irradiation (median dose 500 cGy), five patients (18.5%) with high-dose Cy (median 120 mg/kg). Graft-vs.-host disease (GVHD) prophylaxis was carried out with cyclosporin A in 26 cases; methotrexate (MTX) was added in eight cases. One patient received MTX alone. The median follow-up was 36 months. Ninety-two percent of patients (25 out of 27) engrafted, grade II and III acute GVHD occurred in 28% and 8% of patients, respectively, with chronic GVHD in 12.5%. Conditioning-related toxicity was mild: 4% of patients had grade III mucositis, 7.4% had grade II haemorrhagic cystitis, 14.8% had grade III liver toxicity and 11.1% had grade III renal toxicity. Transplant-related mortality at 12 months was 19.2%, survival at 36 months was 81.5%, with a median Karnofsky score of 100%. No late tumours occurred after a mean follow-up of the survivors of 5 years. None of the studied variables significantly affected the survival, including conditioning regimen, acute GVHD and clinical non-haematological phenotype. Among the studied variables, only conditioning regimens containing high-dose Cy and the presence of genital abnormalities were significantly (P < 0.05) associated with an increased rate of acute GVHD. Our study demonstrates that the Italian FA patients undergoing SCT from an HLA-matched related donor have a very good outcome. These patients, when compared with others of different ethnic origin who underwent allogeneic bone marrow transplantation, showed a less severe non-haematological phenotype, raising the possibility that this milder phenotype may have, at least in part, contributed to the outcome. Our data may provide a useful tool for further studies aiming to correlate genotype with phenotype.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-1048
pubmed:author
pubmed:issnType
Print
pubmed:volume
112
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
796-805
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11260086-Adolescent, pubmed-meshheading:11260086-Bone Marrow Transplantation, pubmed-meshheading:11260086-Child, pubmed-meshheading:11260086-Child, Preschool, pubmed-meshheading:11260086-Congenital Abnormalities, pubmed-meshheading:11260086-Fanconi Anemia, pubmed-meshheading:11260086-Female, pubmed-meshheading:11260086-Genotype, pubmed-meshheading:11260086-Graft vs Host Disease, pubmed-meshheading:11260086-Growth Disorders, pubmed-meshheading:11260086-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11260086-Histocompatibility Testing, pubmed-meshheading:11260086-Humans, pubmed-meshheading:11260086-Italy, pubmed-meshheading:11260086-Male, pubmed-meshheading:11260086-Phenotype, pubmed-meshheading:11260086-Pigmentation Disorders, pubmed-meshheading:11260086-Retrospective Studies, pubmed-meshheading:11260086-Transplantation, Homologous, pubmed-meshheading:11260086-Transplantation Conditioning, pubmed-meshheading:11260086-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.
pubmed:affiliation
Department of Paediatric Haematology-Oncology and BMT Unit, IRCCS G. Gaslini, Largo G. Gaslini 5, 16148 Genoa, Italy. carlodufour@ospedale-gaslini.ge.it
pubmed:publicationType
Journal Article, Comparative Study, Multicenter Study